Scientists are still learning about COVID-19 and how long immunity from previous infection and/or vaccination can last. Meridian is now enrolling participants of all ages for a research study of an investigational blood test intended to assess cell-mediated immune (CMI) response following SARS-CoV-2 natural infection and/or COVID-19 vaccination using vaccines targeting the viral spike (S) protein of SARS-CoV-2 virus.
- Must have either tested positive for COVID-19 within the last 14 days to 24 weeks, or never been infected with COVID-19
- May or may not have completed COVID-19 vaccination
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240 (Savannah) or (402) 934-7563 (Cincinnati).
Submit your information
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.